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Background: Low-cost practical and reliable tools to evaluated obesity-related cardiometabolic diseases are of
clinical practice and public heath relevance worldwide. The aims of this cross-sectional study were to determine the
anatomical point of waist circumference that best identify overweight, obesity and central obesity in Southeast
Brazilian middle-aged men and to test the relationships of its cutoff points with metabolic syndrome (MetS), insulin
resistance (IR) and cardiometabolic risk factors.
Methods: Three hundred men [age: 51 (47–54)] underwent anthropometric, body composition, clinical,
sociodemographic and blood plasma biochemical evaluations.
Results: The umbilical line circumference (WCUL) was the best predictor for overweight (total body fat≥ 20%;
cutoff point: 88.8 cm), obesity (total body fat≥ 25%; cutoff point: 93.4 cm) and central obesity (abdominal area
fat≥ 34.6%; cutoff point: 95.6 cm) as measured by dual beam X-ray absorptiometry. Subjects with WCUL≥ 88.8 cm
or≥ 93.4 cm showed significantly higher values for MetS, IR and cardiometabolic risk factors (i.e. glucose and lipid
profiles, blood pressure). The occurrence of WCUL≥ 88.8 cm was positively associated (p <0.01) with the prevalence
of MetS and cardiometabolic risk factors and increased the central obesity prevalence by 19.3% while that of
WCUL≥ 93.4 cm was associated with the prevalence of MetS, IR and cardiometabolic risk factors.
Conclusions: WCUL measure seems to be the best predictor for overweight, obesity and central obesity in urban
residents Southeast Brazilian middle-aged men; and the WCUL cutoff point (88.8 cm) is significantly associated with
MetS, IR and cardiometabolic risk factors in the studied population.
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Obesity is a major public health problem worldwide. The
accumulation of fat in the body, especially in the central
region, is positively associated with the development of
chronic non-communicable diseases (NCDs) [1-4].
Metabolic syndrome (MetS) is characterized by an ag-
gregation of relevant cardiometabolic risk factors, such* Correspondence: alessandro@ufsj.edu.br
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article, unless otherwise stated.as abdominal obesity, dyslipidaemia, high blood pressure
and high fasting blood glucose [3]. Metabolic syndrome
is more prevalent in Brazilian subjects over 40 years of
age, with prevalence ranging from 23% up to 39.2%, de-
pending on the geographic region, gender, age and criteria
of diagnosis [5,6]. Insulin resistance (IR) is a common
pathologic state in which target cells fail to respond to or-
dinary levels of circulating insulin and, like MetS, it is an
important metabolic risk factor for diabetes and car-
diovascular diseases [7]. However, no data on IR preva-
lence in the Brazilian population is available and IR istral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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diagnosis of MetS, making it a matter of debate [8].
The early diagnosìs of MetS, IR and related cardiomet-
abolic risk factors in populations is of clinical import-
ance and economical relevance. Nevertheless, the
diagnosis of both MetS and IR in large-scale populations
is limited by the high cost of biochemical analyses and
the exposure of the volunteer to invasive procedures (i.e.
discomfort to locate the anatomical points for anthropo-
metric measurements; and blood collection). Thus, low-
cost practical and reliable measurements such as central
circumferences are of clinical and public health rele-
vance worldwide. The waist circumference (WC) measure
has been shown as a good predictor for central obesity
[2,9] and hence cardiometabolic risk factors [10], IR [11]
and MetS prevalence [12]. However, there are limitations
in the use of such measure (i.e. midpoint between the su-
perior border of the iliac crest and inferior margin of the
rib), mainly in overweight and obese subjects, as some
anatomical points are not precisely identified on them
[13,14]. Moreover, the lack of a standardized method for
WC measures by the organizations responsible for NCDs
standards hinders comparison between different geo-
graphic regions [15,16].
Along with early diagnosis of NCDs by using simple
measurements, it is important to set cutoff points for spe-
cific populations as WC differs among different ethnic
groups due to distinct prevalence of cardiometabolic risks
[17]. Previous studies have suggested different values of
WC cutoff points for the diagnosis of obesity and chronic
diseases as compared to those generally used (i.e. Alberti
et al. [3]: 90 cm for South American population) [18,19].
For example, 94 cm for 21–95 old Latin Americans
(Mexico, El Salvador, Venezuela, Colombia and Paraguay)
[18] men as well as 90.2 cm [19] and 88 cm [20] for urban
residents in the northeast region of the Brazil aged 20–59
years were suggested. However, studies suggesting WC
cutoff points for the early detection of NCDs, specifically
in Brazilian middle-aged men (40–59 years old), are not
found.
Therefore, this study was carried out to: (a) determine
one anatomical point of WC that best identify overweight,
obesity and central obesity in urban resident Southeastern
Brazilian middle-aged men; and (b) test the relationships
of its cutoff points with MetS and IR prevalence and, car-
diometabolic risk factors in this population.
Methods
Study population
This cross-sectional study was carried out between
March and December 2011. By convenience, we studied
the population of middle-aged men who were staff
members of the Federal University of Viçosa, located in
the Brazilian southeastern city of Viçosa, Minas Geraisstate. This population consisted of 1,774 (N) men aged
between 40–59 years. The sample size was calculated
using the confidence level of 95% and the prevalence for
obesity in Brazilian men (i.e. 17.5%), as detected by the
Brazilian Health Minister [4], and 4% of sampling error,
which resulted in 291 (n) participants as a minimum
sample size required. The Epi Info software, version
6.04, for cross-sectional studies [21] was used to esti-
mate sample size.
To select the subjects of this study all 1,774 staff mem-
bers were listed and numbered alphabetically and those
numbered multiple of 6 (N/n: 1,774/291) were chosen.
In the event of meeting the exclusion criteria the subject
was replaced by his predecessor in the list. Eight hun-
dred fifty-six subjects were interviewed and 300 of them
were eligible to take part in the present study.
This study excluded subjects who self-declared: body
weight alterations of ≥ 3 kg, altered levels of physical activ-
ity and eating habits in the three months preceding the
study; thyroid diseases, heart failure, cerebrovascular dis-
eases, infectious and/or inflammatory diseases, diseases of
the gastrointestinal tract, liver and chronic kidney and/or
history of kidney stones, cancer in the previous ten years,
eating disorders (anorexia and bulimia) and food allergies.
Subjects using diuretics or drugs that could alter food in-
take and/or metabolism of nutrients were also excluded.
Pacemaker and/or prosthetic users were excluded as it
could affect the DXA result analyses. Elite athletes were
excluded as they could exhibit an inflammatory condition
due to exercise training stress.
This study is in accordance with the resolution 196/96
from the Brazilian Ministry of Health regarding research
involving human subjects and was approved by the
Ethics Committee on Human Research of the Federal
University of Viçosa (Of. Ref. n° 069/2010/CEPH). Only
participants who signed the consent form in accordance
with the Declaration of Helsinki were selected.Anthropometry and body composition measurements
Anthropometry and body composition measurements
were carried out after a 12-hour fast and the subjects
were instructed to perform no physical activities of mod-
erate and high intensity and no caffeine and alcohol in-
gestion in the 48 hours prior to the test.
Body weight and height were determined following the
protocol described by Gordon et al. [22], using a digital
scale with stadiometer (2096PP, Toledo, São Bernardo
do Campo, SP, Brazil). Body mass index (BMI) was cal-
culated using the equation proposed by Quetelet and
the subjects were categorized as: eutrophic (18.5 to
24.9 kg/m2), overweight (25.0 to 29.9 kg/m2) or obese
(≥30 kg/m2), according to the criteria set by the World
Health Organization [23].
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tomical points: (a) narrowest waist (WCNR) [24] (i.e.
nearly 1 cm below the last rib); (b) midpoint between
the superior border of the iliac crest and inferior margin
of the rib (WCMD) [2,3] (i.e. nearly 3 cm above the um-
bilical line); and (c) at the umbilical line (WCUL) [25].
Waist circumferences were measured in triplicate using a
flexible, no stretching tape (TR4010, Sanny, São Bernardo
do Campo, SP, Brazil) and the average value for each ana-
tomical point was considered for data analyses.
Total body scan was performed by dual beam X-ray
absorptiometry (DXA) (LUNAR, GE, Encore software
version 13:31, Madison, WI, USA) to determine the per-
centages of total body fat (%BF) and abdominal area fat
(%AAF). Abdominal area fat is the body fat detected in
the area between the superior border of the iliac crest
and the inferior border of the last rib. Overweight and
obesity cutoff values were set at 20% and 25% of %BF
[26,27], respectively. Since there is no cutoff points for
%AAF reported, the percentage found in the 75th
percentile of %AAF in the present sample was used for
central obesity.
Blood pressure, blood glucose, insulin and serum lipid
profile measurements
Systolic (SBP) and diastolic blood (DBP) pressure were
measured using an automatic inflation blood pressure
monitor (BP3AA1-1, G-Tech, OnboElectronicCo, Schenzen,
China), registered at ANVISA (No. 80275310004), following
the VI Brazilian Guidelines on Hypertension [28].
Blood samples were collected from the antecubital vein
and the serum was separated by centrifugation at 2.225 g
for 15 min at room temperature (Sigma 2–3, Sigma Labor-
zentrifuzen, OsterodeamHarz, Germany). Blood glucose
was measured using the glucose oxidase method (Cobas
Mira Plus, Roche Diagnostics, GmbH, Montclair, NJ, USA),
and insulin was measured by electrochemiluminescence
(Modular Analytics, E170, Roche Diagnostics, GmbH,
Mannheim, Germany).
Serum total cholesterol, high-density lipoprotein (HDL-
C) and triglycerides were determined by an enzymatic col-
orimetric method (Cobas Mira Plus, Roche Diagnostics
GmbH, Montclair, NJ, USA). The atherogenic index was
calculated as the total cholesterol to HDL-C ratio [29].
Determination of metabolic syndrome, insulin resistance
and cardiometabolic risk factors
The MetS was considered prevalent in subjects who exhib-
ited three or more factors related to waist circumference
(WCMD ≥ 90 cm), hyperglycaemia (glucose ≥ 100 mg/dL),
dyslipidaemia (HDL-C < 40 mg/dL), hypertriglyceridemia
(≥150 mg/dL) and/or high blood pressure (SBP ≥
130 mmHg or DBP ≥ 85 mmHg), according to the criteria
and cutoff points suggested by Alberti et al. [3].The homeostasis model assessment (HOMA-IR) was
used to estimate IR by using the equation proposed by
Matthews et al. [30]. The cutoff value used for the IR
diagnosis was 2.7 as suggested by Geloneze et al. [31].
The following values were set as cardiometabolic risk
factors [32,33]: triglycerides ≥ 150 mg/dl (hypertriglyc-
eridemia); total cholesterol ≥ 200 mg/dl and HDL-C <
40 mg/dl (dyslipidaemia) and glucose ≥ 99 mg/dl (hyper-
glycaemia). The participants were classified as hyperten-
sive when systolic and diastolic blood pressures were ≥
140 and ≥ 90 mmHg, respectively, [28] and it was con-
sidered a cardiometabolic risk when atherogenic index
was ≥ 5 [29].
Lifestyle
The subjects who participated in this study occupied
working positions classified as levels A, B, C, D, and E, or
professor. To evaluate how lifestyle and occupation influ-
enced the level of physical activity they were grouped ac-
cording to their education level and working positions:
Group ABC was composed of technical and administrative
staff members, classified as A, B and C, with an education
level up to high school. Group DEProf was composed of
technical and administrative staff members levels D and E
and professors, all college-educated.
The participants were asked about their current smoking
status (yes/no) and alcohol consumption (types of alcoholic
beverages consumed - beer, wine and/or spirits, frequency
and weekly quantity in mL). High alcohol consumption was
defined as a weekly intake over 21 units [34].
The full version of the International Physical Activity
Questionnaire [35] was applied and subjects were catego-
rized as sedentary/moderately active or active/very active.
Statistical Analysis
Data normality was assessed by the “Smirnov-Kolmogorov”
test. For data exposure, we used descriptive statistics com-
posed by mean values and standard deviation or median
and interquartile range for continuous variables and fre-
quency for categorical variables. After logarithmic trans-
formation the WCNR, WCMD and WCUL values were
compared by ANOVA one way followed by the post hoc
Tukey test. The physical activity levels were compared
using Chi-Square. The Student’s t test was used for inde-
pendent samples, or its nonparametric equivalent, the
Mann-Whitney test, to confirm the existence of differ-
ences between mean values per group.
The receiver operating characteristic curve (ROC) was
used to detect the best circumference cutoff, sensitivity
(Sens) and specificity (Spec) in relation to the cutoff
points: 21%BF and 25%BF and 34.6%AAF. The areas
under the curve and confidence intervals of 95% (95% CI)
were also determined. The univariate and multivariate
regression analysis according to Poisson was used to
Table 1 General characteristics of the studied subjects
Age (y) 51 (47–54)a
ABC work position (number/%)b 199/66.3
High alcohol consumption (number/%) 61/20.3
Smokers (number/%) 38/12.7
Physical activity levels (number/%)
Sedentary or moderately active 92/30.6
Active or very active 208/69.4#
Body mass index (kg/m2) 25.8 ± 3.43
Total body fat (%) 22.76 ± 7.14
Abdominal area fat (%) 26.34 ± 10.52
WCNR (cm) 88.7 ± 8.4
WCMD (cm) 90.4 ± 9.5
WCUL (cm) 92.2 ± 9.3
*
Systolic blood pressure (mmHg) 126 ± 14
Diastolic blood pressure (mmHg) 81 ± 10
Glucose (mg/dl) 89 (83–95)
Insulin (μIU/mL) 5.2 (3.4-8.1)
HOMA-IR 1.14 (0.73-1.81)
Total cholesterol (mg/dl) 214.8 ± 40.9
HDL-C (mg/dl) 44 (38–53)
Triglycerides (mg/dl) 116.5 (82.5-166)
Atherogenic index 4.68 (3.82-5.60)
n = 300; WCNR, waist circumference at the narrowest waist, WCMD, waist
circumference at the midpoint between the superior border of the iliac crest and
the inferior margin of the rib, WCUL, waist circumference at the umbilical line.
HOMA-IR, insulin resistance index; HDL-C, high density lipoprotein-cholesterol.
aData are mean ± SD or median and interquartile range of 300 subjects,
according to normal distribution of the variables.
bABC: technical staff at A, B and C work positions.
*Statistically different from WCNR and WCMD.
#Statistically different from Sedentary or moderately active.
de Oliveira et al. Lipids in Health and Disease 2014, 13:141 Page 4 of 8
http://www.lipidworld.com/content/13/1/141estimate the prevalence ratio (95% CI) of subjects with
hyperglycaemia, dyslipidaemia, hypertensive and MetS
(dependent variables). In these analyses the WC cutoff
point (88.8 cm) served as independent variable and the
lifestyle factors as covariates.
Data processing and analysis were carried out with the
software SPSS version 16.0 (SPSS Inc. Chicago, IL, USA)
and STATA 9.1. The value used for all variables and
two-tailed analyses was p # 0.05.
Results
The general characteristics of the participants are shown
in Table 1. There was a high incidence of technical ad-
ministrative staff members, moderate prevalence of high
alcohol consumption (20.3%) and low prevalence of
smoking (12.7%). In addition, most participants were
self-declared as physically active or very active (69.4%).
The BMI assessment showed overweight and obesity in
42.6% and 12.3% of subjects, respectively. The following
prevalence percentages were observed: 61.7% for dyslipi-
daemia, 30.7% for hypertriglyceridemia, 37.7% for high
atherogenic index, 34.3% for hypertension, 18.3% for
hyperglycaemia and 9% for IR. There was a prevalence
of 28.3% for MetS, according to the criteria suggested by
Alberti et al. [3]. After comparing the measured waist
circumferences (WCNR, WCMD, WCUL), we observed no
statistical difference between WCNR and WCMD. How-
ever, WCUL was higher than WCNR and WCMD.
The waist circumference values measured at the three
different anatomical points showed strong and signifi-
cant associations (p ≤ 0.01) with overweight, obesity and
central obesity (Table 2) as determined by DXA. Inter-
estingly, the WCUL was observed as the best measure to
identify the prevalence of overweight and obesity, ac-
cording to the percentages of total body fat (≥20% and ≥
25%, respectively) and of central obesity (abdominal area
fat ≥ 34.6%). The WCUL best cutoff values for over-
weight, obesity and central obesity detection as regard to
the smallest difference between sensitivity and specificity
were 88.8 cm, 93.4 cm and 95.6 cm, respectively.
We used the two smaller WCUL cutoff points (88.8 cm
and 93.4 cm) to test its relationships with Mets, IR and
cardiometabolic risk factors (Table 3). The occurrence of
WCUL ≥ 88.8 cm or 93.4 was positively associated
(p<0.01) with the prevalence of MetS and the cardiomet-
abolic risk factors studied.
We then tested the associations of the prevalence of
MetS, IR and cardiometabolic risk factors with the sug-
gested cutoff points for WCUL (Table 4). Significant
associations of this circumference values for overweight
(i.e. > 88.8 cm) with the diagnosis of hypertension, dysli-
pidaemia, hypertriglyceridemia and lower HDL-C, inde-
pendently of confounding variables (i.e. smoking and
frequency of alcoholic beverage consumption) wereobserved. All subjects diagnosed with insulin resistance
presented WCUL higher than 88.8 cm, which made the
statistical calculation impossible. Moreover, using WCUL
higher than 88.8 cm we observed the increase of 19.3%
in central obesity prevalence as compared to WCMD ≥
90 cm (data not shown). Finally, when we tested the
WCUL cutoff point for obesity (i.e. > 93.4 cm) significant
associations with MetS, IR and cardiometabolic risk fac-
tors were found.Discussion
This study was carried out to determine the anatomical
point of waist circumference measurements that best
identify overweight, obesity and central obesity, as mea-
sured by DXA, in Brazilian middle-aged men residents
in the urban area of Viçosa city in the southeastern re-
gion of the country and to test the relationships of its
cutoff points with metabolic syndrome, insulin resistance
and other cardiometabolic risk factors.
Table 2 AUC (95% CI) for overweight, obesity and central obesity and different anatomical points of central
circumference in middle-aged men
Overweight (>20% BF) Obesity (>25% BF) Central obesity (34.6% AAF)
WCNR
AUC 0.877 (0.839-0.915) 0.905 (0.870-0.940) 0.898 (0.861-0.936)
Cutoff (cm) 86.4 89.4 91.6
Sensitivity (%) 77.6 84.6 80.3
Specificity (%) 77.9 83.6 80.4
WCMD
AUC 0.909 (0.877-0.942) 0.919 (0.890-0.948) 0.897 (0.861-0.933)
Cutoff (cm) 87.3 91.4 93.8
Sensitivity (%) 82.1 83.8 80.3
Specificity (%) 82.7 82.0 79.9
WCUL
AUC 0.925 (0.893-0.953) 0.923 (0.894-0.952) 0.902 (0.861-0.942)
Cutoff (cm) 88.8 93.4 95.6
Sensitivity (%) 82.5 84.6 81.6
Specificity (%) 83.0 84.7 81.2
AUC, area under curve. CI, confidence intervals. WCUL, waist circumference at the umbilical line. WCMD, waist circumference at the midpoint between the superior
border of the iliac crest and the inferior margin of the rib. WCNR, waist circumference at the narrowest waist.
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WCMD and WCNR and, therefore, it was more accurate
in the identification of overweight and obesity making
our results in line with the cutoff points recommended
by SEEDO [26] and suggested by Bray et al. [27]. We
also found that this circumference measure was strongly
associated with %AAF (75th percentile), which makes of
it also an accurate measure to identify central obesity.
These results confirm the association of WC measure-
ments with total and central adiposity as observed previ-
ously in different populations of similar ages. For example,Table 3 Cardiometabolic risk factors in relation with cutoff of po
Cutoff WCUL
a
< 88.8 cm (n = 120) ≥ 88.8 cm (n = 180)
Glucose (mg/dl) 85 (81–93)c 90 (85–97)
HOMA-IR 0.74 (0.52-1.05) 1.58 (1.09-2.22)
Total cholesterol (mg/dl) 206.1 ± 38.0 220.0 ± 41.9
HDL-C (mg/dl) 48 (41–57) 43 (37–50)
Triglycerides (mg/dl) 90 (70–127) 136 (101–208)
Atherogenic index 4.15 (3.46-4.97) 4.93 (4.27-5.92)
Triglycerides/HDL-C 1.85 (1.36-2.74) 3.31 (2.11-4.90)
Systolic blood
pressure (mmHg)
122.1 ± 13.1 128.7 ± 13.6
Diastolic blood
pressure (mmHg)
77.5 ± 9.0 83.4 ± 9.5
WCUL: Waist circumference at the umbilical line; HDL-C: high density lipoprotein cho
of subjects.
apercentage of body fat cutoff points suggested as for the best sensitivity and spec
bp-values from Student t-test or Mann–Whitney test.
cData are mean ± SD or median and interquartile range.similar findings were demonstrated in male urban resi-
dents in a city in the northeast of Brazil [19,20] and also in
men from other Latin American countries [18]. Likewise,
these associations were found in Canadian (20–79 years
old) [15] and Japanese (40–65 years old) [36] men. It is
noteworthy that our data indicate the WCUL as the best
anatomical point to identify overweight, obesity and cen-
tral obesity. This anthropometric indicator is of practical
and clinical relevance in the professional field for both
subject assessment and population-based studies. WCUL





< 93.4 cm (n = 173) ≥ 93.4 cm (n = 127)
< 0.001 87 (82–93) 90 (85–97) < 0.001
< 0.001 0.84 (0.61-1.17) 1.76 (1.23-2.49) < 0.001
0.004 206.1 ± 36.4 225.7 ± 44.0 < 0.001
< 0.001 46 (40–55) 42 (37–50) 0.004
< 0.001 99 (72–139) 143 (107–246) < 0.001
< 0.001 4.37 (3.59-5.10) 5.05 (4.30-6.42) < 0.001
< 0.001 2.06 (1.52-3.31) 3.56 (2.35-5.79) < 0.001
< 0.001 129.3 ± 13.6 123.8 ± 13.5 0.001
< 0.001 78.8 ± 9.2 84.1 ± 9.6 < 0.001
lesterol; HOMA-IR: homeostatic model assessment insulin resistance; n: number
ificity relation (see Table 2).
Table 4 Prevalence ratio of MetS, and cardiometabolic risk factors in relation with cutoff points for WCUL calculated
using a univariate and multivariate regression analysis according to Poisson
≥ 88.8 cm WCULa ≥93.4 cm WCULa
Non adjustedb
High fast glucosed 1.778 (1.028-3.073)* 1.519 (0.942-2.450)
Insulin resistancee *** 7.833 (2.773-22.128)**
High total cholesterolf 1.174 (0.967-1.422) 1.291 (1.083-1.538)**
Low HDL-Cg 1.316 (1.126-1.538)** 1.295 (1.085-1.545)**
High triglyceridesh 2.561 (1.634-4.015)** 2.554 (1.776-3.673)**
Atherogenic indexi 2.123 (1.472-3.062)** 1.844 (1.374-2.477)**
High systolic blood pressurej 1.548 (1.088-2.203)* 1.501 (1.099-2.051)*
High diastolic blood pressurek 2.000 (1.354-2.954)** 1.881 (1.359-2.603)**
Metabolic Syndromel 3.917 (1.917-8.001) ** 4.401 (2.466-7.855) **
After Adjustmentc
High fast glucosed 1.936 (1.129-3.318)* 1.632 (1.018-2.615)*
Insulin resistancee *** 6.829 (2.414-19.317)**
High total cholesterolf 1.154 (0.952-1.400) 1.271 (1.066-1.515)**
Low HDL-Cg 1.361 (1.165-1.591)** 1.327 (1.113-1.582)**
High trygliceridesh 2.516 (1.604-3.946)** 2.500 (1.730-3.611)**
Atherogenic indexi 1.896 (1.418-2.534)** 2.217 (1.543-3.186)**
High systolic blood pressurej 1.565 (1.100-2.227)* 1.549 (1.139-2.107)**
High diastolic blood pressurek 1.987 (1.346-2.934)** 1.894 (1.366-2.625)**
Metabolic Syndromel 4.308 (2.130-8.727)** 4.789 (2.713-8.452)**
Data are expressed as prevalence ratio (95% confidence interval); MetS: metabolic syndrome; WCUL: waist circumference at the umbilical line; HDL-C: high density
lipoprotein cholesterol.
atwo smaller cutoff points suggested as of the best sensitivity and specificity relation (see Table 2).
bnon-adjusted.
cadjusted for age, work position, physical activity level, smoker and alcohol consumption.
dglucose > 99 mg/dl.
ehomeostatic model assessment insulin resistance (HOMA-IR) > 2.7.
fTotal cholesterol > 200 mg/dl.
gHDL-C < 40 mg/dl.
hTriglycerides > 150 mg/d.
iTotal cholesterol/HDL-C > 5.
jsystolic blood pressure ≥ 140 mmHg.
kdiastolic blood pressure ≥ 90 mmHg.
lMetabolic Syndrome prevalence by Alberti et al., [3].
*p ≤ 0.05; **p ≤ 0.01; ***no data (null prevalence in one group).
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pared to WCNR and WCMD, especially in obese subjects.
Our results showed significant associations of the cut-
off points for WCUL (88.8 cm and 93.4 cm) with MetS,
IR and other cardiometabolic risk factors assessed in this
population. For instance, higher values for serum lipid
profile, blood pressure and blood glucose, and a higher
prevalence of MetS in subjects with WCUL greater than
88.8 cm were observed. In addition, the prevalence
of MetS, IR and cardiometabolic risk factors examined
were even higher in subjects with WCUL above 93.4 cm.
Previous studies in different Brazilian geographical
regions have pointed to a strong relationship between
obesity, especially the central fat accumulation, and the
occurrence of NCDs [37]. Thus, our data reinforce those
previously reported for the Brazilian population andsupport the idea that the cutoff points obtained (88.8 cm
and 93.4 cm) are of clinical and economic importance
for risk assessment and prevention of obesity related
diseases in this population, especially because Brazilian
middle-aged men have high prevalence for mortality and
morbidity related to NCDs [38].
Our findings represent a scenario in an apparently
healthy middle-aged male population. The selected subjects
who self-declared suffering from different diseases or disor-
ders or taking medicines that could alter food intake and/or
metabolism of nutrients were excluded from our study. In
fact, the participants exhibited moderate alcohol consump-
tion, low prevalence of smoking and were physically active.
Despite that, the prevalence for overweight, dyslipidaemia,
hypertriglyceridemia, high atherogenic index and hyperten-
sion was over 30%. Although these data reflect the reality of
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metabolic diseases at this age, it cannot be extended to the
national Brazilian population since there are regional ethnic
groups and differences in eating habits across the country.
In addition, it is worth to note that the suggested cutoff
value for WCUL cannot be generalized to all central circum-
ferences measures as this may lead to possible errors of in-
terpretation and misdiagnosis. In fact, in the present study
population WCUL was higher than both WCNR and WCMD,
which were not statistically different when compared to
each other. Moreover, the increase of 19.3% in the central
obesity prevalence using WCUL ≥ 88.8 cm enables more ac-
curate for cardiometabolic risk factors diagnosis.
Finally, our study presents some limitations: (a) despite
the fact that the sample size was justified in relation to the
target population, studies on larger populations including
both gender residents in different regions of Brazil are
needed to set cutoff points to the early diagnoses of NCDs
nationwide; and (b) although the associations of the WCUL
cutoff point with MetS, IR and cardiometabolic risk factors
remained after being adjusted for age, working position,
physical activity level, smoking and alcohol consumption,
other factors such as eating habits, marital status and family
income were not included.
Overall, this cross-sectional study support the conclu-
sions that: (a) the WCUL measure seems to be the
best anatomical point to perform waist circumference
measurement to identify overweight, obesity and central
obesity in urban Southeast Brazilian middle-aged men;
and (b) the WCUL cutoff point (88.8 cm) is significantly
associated with MetS, IR and cardiometabolic risk fac-
tors in the studied population.
Abbreviation
NCDs: Non-communicable diseases; MetS: Metabolic syndrome; IR: Insulin
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between the superior border of the iliac crest and inferior margin of the rib;
WCUL: Waist circumference measure on umbilical line; DXA: Dual beam X-ray
absorptiometry; %BF: Total body fat; %AAF: Abdominal area fat; SBP: Systolic
blood pressure; DBP: Diastolic blood pressure; HDL-C: High-density
lipoprotein; HOMA-IR: Homeostasis model assessment insulin resistance;
AUC: Area under curve; ROC: Receiver operating characteristic curve;
Sens: Sensitivity; Spec: Specificity.
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